Literature DB >> 20185038

Prognostic importance of atrial fibrillation in implantable cardioverter-defibrillator patients.

C Jan Willem Borleffs1, Johannes B van Rees, Guido H van Welsenes, Enno T van der Velde, Lieselot van Erven, Jeroen J Bax, Martin J Schalij.   

Abstract

OBJECTIVES: This study aimed to assess the prevalence of different types of atrial fibrillation (AF) and their prognostic importance in implantable cardioverter-defibrillator (ICD) patients.
BACKGROUND: The prevalence of AF has taken epidemic proportions in the population with cardiovascular disease. The prognostic importance of different types of AF in ICD patients remains unclear.
METHODS: Data on 913 consecutive patients (79% men, mean age 62 + or - 13 years) receiving an ICD at the Leiden University Medical Center were prospectively collected. Among other characteristics, the existence and type of AF (paroxysmal, persistent, or permanent) were assessed at implantation. During follow-up, the occurrence of appropriate or inappropriate device therapy as well as mortality was noted.
RESULTS: At implantation, 73% of patients had no history of AF, 9% had a history of paroxysmal AF, 7% had a history of persistent AF, and 11% had permanent AF. During 833 + or - 394 days of follow-up, 117 (13%) patients died, 228 (25%) patients experienced appropriate device discharge, and 139 (15%) patients received inappropriate shocks. Patients with permanent AF exhibited more than double the risk of mortality, ventricular arrhythmias triggering device discharge, and inappropriate device therapy. Patients with paroxysmal or persistent AF did not show a significant increased risk of mortality or appropriate device therapy but demonstrated almost 3 times the risk of inappropriate device therapy.
CONCLUSIONS: In the population currently receiving ICD treatment outside the setting of clinical trials, a large portion has either a history of AF or permanent AF. Both types of AF have prognostic implications for mortality and appropriate as well as inappropriate device discharge. Copyright 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20185038     DOI: 10.1016/j.jacc.2009.09.053

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  13 in total

1.  Nonpharmacological Treatment of Atrial Fibrillation: What Is the Role of Device Therapy?

Authors:  Lucie Riedlbauchová; Václav Durdil; Jakub Honěk; Josef Veselka
Journal:  Int J Angiol       Date:  2020-04-28

2.  The Significance of Shocks in Implantable Cardioverter Defibrillator Recipients.

Authors:  Anthony Li; Amit Kaura; Nicholas Sunderland; Paramdeep S Dhillon; Paul A Scott
Journal:  Arrhythm Electrophysiol Rev       Date:  2016-08

Review 3.  Comorbidity of atrial fibrillation and heart failure.

Authors:  Liang-Han Ling; Peter M Kistler; Jonathan M Kalman; Richard J Schilling; Ross J Hunter
Journal:  Nat Rev Cardiol       Date:  2015-12-10       Impact factor: 32.419

Review 4.  Atrial fibrillation is associated with sudden cardiac death: a systematic review and meta-analysis.

Authors:  Pattara Rattanawong; Sikarin Upala; Tanawan Riangwiwat; Veeravich Jaruvongvanich; Anawin Sanguankeo; Wasawat Vutthikraivit; Eugene H Chung
Journal:  J Interv Card Electrophysiol       Date:  2018-01-13       Impact factor: 1.900

5.  European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population.

Authors:  Jens Cosedis Nielsen; Yenn-Jiang Lin; Marcio Jansen de Oliveira Figueiredo; Alireza Sepehri Shamloo; Alberto Alfie; Serge Boveda; Nikolaos Dagres; Dario Di Toro; Lee L Eckhardt; Kenneth Ellenbogen; Carina Hardy; Takanori Ikeda; Aparna Jaswal; Elizabeth Kaufman; Andrew Krahn; Kengo Kusano; Valentina Kutyifa; Han S Lim; Gregory Y H Lip; Santiago Nava-Townsend; Hui-Nam Pak; Gerardo Rodríguez Diez; William Sauer; Anil Saxena; Jesper Hastrup Svendsen; Diego Vanegas; Marmar Vaseghi; Arthur Wilde; T Jared Bunch; Alfred E Buxton; Gonzalo Calvimontes; Tze-Fan Chao; Lars Eckardt; Heidi Estner; Anne M Gillis; Rodrigo Isa; Josef Kautzner; Philippe Maury; Joshua D Moss; Gi-Byung Nam; Brian Olshansky; Luis Fernando Pava Molano; Mauricio Pimentel; Mukund Prabhu; Wendy S Tzou; Philipp Sommer; Janice Swampillai; Alejandro Vidal; Thomas Deneke; Gerhard Hindricks; Christophe Leclercq
Journal:  Europace       Date:  2020-08-01       Impact factor: 5.214

6.  Outcomes of patients with heart failure after primary prevention ICD unit generator replacement.

Authors:  Khang-Li Looi; Andrew Gavin; Lisa Cooper; Liane Dawson; Debbie Slipper; Nigel Lever
Journal:  Heart Asia       Date:  2019-02-28

7.  Low-dose green tea intake reduces incidence of atrial fibrillation in a Chinese population.

Authors:  Dong-Chen Liu; Jian-Jun Yan; You-Nan Wang; Ze-Mu Wang; Zhi-Yong Xie; Yao Ma; Yang Yang; Li Yang; Lian-Sheng Wang
Journal:  Oncotarget       Date:  2016-12-20

8.  Atrial Fibrillation Is Associated With Higher Overall Mortality in Patients With Implantable Cardioverter-Defibrillator: A Systematic Review and Meta-Analysis.

Authors:  Usman Mustafa; Parinita Dherange; Rohit Reddy; Joseph DeVillier; Jessica Chong; Alarozia Ihsan; Ryan Jones; Narendra Duddyala; Pratap Reddy; Paari Dominic
Journal:  J Am Heart Assoc       Date:  2018-11-20       Impact factor: 5.501

9.  Clinical factors associated with baseline history of atrial fibrillation and subsequent clinical outcomes following initial implantable cardioverter-defibrillator placement.

Authors:  Shaun Giancaterino; Marin Nishimura; Ulrika Birgersdotter-Green; Kurt S Hoffmayer; Frederick T Han; Farshad Raissi; Gordon Ho; David Krummen; Gregory K Feld; Jonathan C Hsu
Journal:  Pacing Clin Electrophysiol       Date:  2020-05-02       Impact factor: 1.976

Review 10.  Atrial fibrillation in heart failure: an innocent bystander?

Authors:  M A Khan; L Neyses; M A Mamas
Journal:  Curr Cardiol Rev       Date:  2012-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.